The Impact of Probiotics in Respiratory Diseases
DOI:
https://doi.org/10.25156/ptj.v10n1y2020.pp148-156Keywords:
Lactic acid bacteria, Microorganism, Probiotics, Pulmonary disease, Respiratory diseaseAbstract
Probiotics are viable microorganisms that, if adequately administered, confer great benefits to the host for the prevention or treatment of a wide range of human diseases, including recurrent respiratory tract infection (RRTI), cystic fibrosis, allergies, and chronic obstructive pulmonary disease (COPD). One of the current problems is that the overuse of antibiotics during respiratory tract infection has led to increased resistance to them, which has been demonstrated in numerous examinations that specific lactic acid bacteria (LAB), one of the key probiotics, against bacterial and viral infections of the respiratory and gastrointestinal tract, have a protective effect. On the other hand, changes in the gastrointestinal and respiratory microbiomes, especially lactobacilli and bifidobacteria, lead to an increase in allergies and asthma and a balance in the microbiome may improve symptoms. Probiotics are able to increase the number and activity of leukocytes, neutrophils, and NK cells. They can also increase IL-10 expression and decrease the expression of inflammatory cytokines such as TNF-α, IL-1β, and IL-8. In addition, they maintain high levels of IgA and produce bacteriocin and ruterin that have antimicrobial activity. Without identifying the specific properties of the probiotic strains and identifying the precise mechanism of their action, probiotic treatment would only be a large hypothesis because the therapeutic and clinical outcomes are different. On the other hand, metagenomics have provided information on how the microbiome interacts with host physiology, leading to new therapeutic targets.
Downloads
References
Allen, E. K., A. F. Koeppel, J. O. Hendley, S. D. Turner, B. Winther and M. M. Sale. 2014. Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome. 2: 22.
Alvarez, S., C. Herrero, E. Bru and G. Perdigon. 2001. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. J. Food Protect. 64: 1768-1774.
Anderson, J. L., C. Miles and A. C. Tierney. 2017. Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review. J. Cyst. Fibros. 16: 186-197.
Asher, M. I., S. Montefort, B. Björkstén, C. K. Lai, D. P. Strachan and S. K. Weiland. 2006. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet. 368: 733-743.
Berrington, J. E., S. P. Cummings and N. D. Embleton. 2014. The nasopharyngeal microbiota: An important window of opportunity. Am. J. Respir. Crit. Care Med. 190: 246-248.
Biesbroek, G., E. Tsivtsivadze, E. A. Sanders, R. Montijn, R. H. Veenhoven and B. J. Keijser. 2014. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am. J. Respir. Cri. Care Med. 190: 1283-1292.
Borody, T. J., E. F. Warren, S. M. Leis, R. Surace, O. Ashman and S. Siarakas. 2004. Bacteriotherapy using fecal flora: Toying with human motions. J. Clin. Gastroenterol. 38: 475-483.
Brown. R. L. and T. B. Clarke. 2017. The regulation of host defences to infection by the microbiota. Immunology. 150: 1-6.
Carvalho, J. L., M. Miranda, A. K. Fialho, H. Castro-Faria-Neto, E. Anatriello and A. C. Keller. 2019. Oral feeding with probiotic Lactobacillus rhamnosus attenuates cigarette smoke-induced COPD in C57Bl/6 mice: Relevance to inflammatory markers in human bronchial epithelial cells. BioRxiv. 2019: 843433.
Chen, J., Z. Xu, X. Ou, M. Wang, X. Yang and Q. Li. 2009. Mannosebinding lectin polymorphisms and recurrent respiratory tract infection in Chinese children. Eur. J. Pediatr. 168: 1305-1313.
Clarke, T. B. 2014. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect. Immun. 82: 4596-4606.
D’souza, A. L., C. Rajkumar, J. Cooke and C. J. Bulpitt. 2002. Probiotics in prevention of antibiotic associated diarrhoea: Metaanalysis. BMJ. 324: 1361.
Davras, F., Z. B. Guzel-Seydim and T. K. Tas. 2018. Immunological effects of Kefir produced from Kefir grains versus starter cultures when fed to mice. Funct. Foods Health Dis. 8: 412-423.
de Araujo G. V., M. H. de Oliveira Junior, D. M. Peixoto and E. S. C. Sarinho. 2015. Probiotics for the treatment of upper and lower respiratory-tract infections in children: Systematic review based on randomized clinical trials. J. Pediatr. 91: 413-427.
Dinleyici, E. C., N. Dalgic, S. Guven, O. Metin, O. Yasa and Z. Kurugol. 2015. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J. Pediatr. 91: 392-396.
Feleszko, W., J. Jaworska, R. D. Rha, S. Steinhausen, A. Avagyan and A. Jaudszus. 2007. Probiotic‐induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory‐dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy. 37: 498-505.
Foligne, B., G. Zoumpopoulou, J. Dewulf, A. B. Younes, F. Chareyre and J. C. Sirard. 2007. A key role of dendritic cells in probiotic functionality. PLoS One. 2: e313.
Forsythe, P. 2011. Probiotics and lung diseases. Chest. 139: 901-908.
Gauguet, S., S. D’Ortona, K. Ahnger-Pier, B. Duan, N. K. Surana and R. Lu. 2015. Intestinal microbiota of mice influences resistance to Staphylococcus aureus pneumonia. Infect. Immun. 83: 4003- 4014.
Gentile, A., A. Bardach, A. Ciapponi, S. Garcia-Marti, P. Aruj and D. Glujovsky. 2012. Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: A systematic review and meta-analysis. Int. J. Infect. Dis. 16: e5-e15.
Goldenberg, J. Z., C. Yap, L. Lytvyn, C. K. F. Lo, J. Beardsley and D. Mertz. 2017. Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children. Cochrane Database Syst. Rev. 12(12): CD006095.
Goldin, B. and S. Gorbach. 2008. Clinical indications for probiotics: An overview. Clin. Infect. Dis. 46: S96-S100.
Gollwitzer, E. S. and B. J. Marsland. 2014. Microbiota abnormalities in inflammatory airway diseases-potential for therapy. Pharmacol. Ther. 141: 32-39.
Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy and K. M. Murphy. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper Type 1 and 2 lineages. Nat. Immunol. 6: 1123.
Hatakka, K., E. Savilahti, A. Pönkä, J. H. Meurman, T. Poussa and L. Näse. 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. BMJ. 322: 1327.
Hill, C., F. Guarner, G. Reid, G. R. Gibson, D. J. Merenstein and B. Pot. 2014. Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11: 506.
Hojsak, I., S. Abdović, H. Szajewska, M. Milošević, Ž. Krznarić and S. Kolaček. 2010. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics. 125: e1171-e1177.
Hori, T., J. Kiyoshima, K. Shida and H. Yasui. 2002. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin. Diagn. Lab. Immunol. 9: 105-108.
Hougee, S., A. Vriesema, S. Wijering, L. Knippels, G. Folkerts and F. Nijkamp. 2010. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: A bacterial strain comparative study. Int. Arch. Allergy Immunol. 151: 107-117.
Joint, F. 2001. WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. World Health Organization, Córdoba, Argentina.
King, S., J. Glanville, M. E. Sanders, A. Fitzgerald and D. Varley. 2014. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: A systematic review and meta- analysis. Br. J. Nutr. 112: 41-54.
Koizumi, S. I., D. Wakita, T. Sato, R. Mitamura, T. Izumo and H. Shibata. 2008. Essential role of toll-like receptors for dendritic cell and NK1. 1+ cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84. Immunol. Lett. 120: 14-19.
Kuitunen, M., K. Kukkonen, K. Juntunen-Backman, R. Korpela, T. Poussa and T. Tuure. 2009. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J. Allergy Clin. Immunol. 123: 335-341.
Li, K. L., B. Z. Wang, Z. P. Li, Y. L. Li and J. J. Liang. 2019. Alterations of intestinal flora and the effects of probiotics in children with recurrent respiratory tract infection. World J. Pediatr. 2019: 1-7.
Li, L. and S. Somerset. 2014. The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies. Clin. Nutr. 33: 571-580.
Liu, S., P. Hu, X. Du, T. Zhou and X. Pei. 2013. Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: A meta-analysis of randomized, placebocontrolled trials. Indian Pediatr. 50: 377-381.
Morimoto, K., T. Takeshita, M. Nanno, S. Tokudome and K. Nakayama. 2005. Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. Prev. Med. 40: 589-594.
Mortaz, E., I. M. Adcock, G. Folkerts, P. J. Barnes, A. Paul Vos and J. Garssen. 2013. Probiotics in the management of lung diseases. Med. Inflamm. 2013: 10.
Noverr, M. C. and G. Huffnagle. 2005 The microflora hypothesis of allergic diseases. Clin. Exp. Allergy. 35: 1511-1520.
O’Mahony, C., P. Scully, D. O’Mahony, S. Murphy, F. O’Brien, A. Lyons, G. Sherlock, J. MacSharry, B. Kiely, F. Shanahan and L. O’Mahony. 2008 Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-κB activation. PLoS Pathog. 4: e1000112.
Oelschlaeger, T. A. 2010. Mechanisms of probiotic actions-a review. Int. J. Med. Microbiol. 300: 57-62.
Oliva, S., G. Di Nardo, F. Ferrari, S. Mallardo, P. Rossi, G. Patrizi, S. Cucchiara and L. Stronati. 2012. Randomised clinical trial: The effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment. Pharmacol. Ther. 35: 327-334.
Othman, M., R. Agüero and H. C. Lin. 2008. Alterations in intestinal microbial flora and human disease. Curr. Opin. Gastroenterol. 24: 11-16.
Peat, J. K., R. H. Van Den Berg, W. F. Green, C. M. Mellis, S. R. Leeder and A. Wolcock. 1994. Changing prevalence of asthma in Australian children. BMJ. 308: 1591-1596.
Perez-Cano, F. J., H. Dong and P. Yaqoob. 2010. In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: Two probiotic strains isolated from human breast milk. Immunobiology. 215: 996-1004.
Pettigrew, M. M., J. F. Gent, R. B. Pyles, A. L. Miller, J. Nokso-Koivisto and T. Chonmaitree. 2011. Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J. Clin. Microbiol. 49: 3750-3755.
Rabe, K. F., S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel and J. Zielinski. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Cri. Care Med. 176: 532-555.
Rao, A. V., A. C. Bested, T. M. Beaulne, M. A. Katzman, C. Iorio and J. M. Berardi. 2009. A randomized, double-blind, placebocontrolled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 1: 6.
Rijkers, G. T., S. Bengmark, P. Enck, D. Haller, U. Herz and M. Kalliomaki. 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: Current status and recommendations for future research. J. Nutr. 140: 671S-676S.
Roca, I., M. Akova, F. Baquero, J. Carlet, M. Cavaleri and S. Coenen. 2015. The global threat of antimicrobial resistance: Science for intervention. New Microbes. New Infect. 6: 22-29.
Rogers, G. B., M. Carroll, L. Hoffman, A. Walker, D. Fine and K. Bruce. 2010. Comparing the microbiota of the cystic fibrosis lung and human gut. Gut Microbes. 1: 85-93.
Salminen, M. K., S. Tynkkynen, H. Rautelin, M. Saxelin, M. Vaara and P. Ruutu. 2002. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin. Infect. Dis. 35: 1155-1160.
Salminen, S., C. Bouley, M. C. Boutron, J. Cummings, A. Franck and G. Gibson. 1998. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80: S147-S171.
Salva, S., J. Villena and S. Alvarez. 2010. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections. Int. J. Food Microbiol. 141: 82-89.
Samuelson, D. R., D. A. Welsh and J. E. Shellito. 2015 Regulation of lung immunity and host defense by the intestinal microbiota. Front. Microbiol. 6: 1085.
Sanz, Y., I. Nadal and E. Sánchez. 2007. Probiotics as drugs against human gastrointestinal infections. Rec. Patents Anti Infect. Drug Discov. 2: 148-156.
Savino, F., L. Cordisco, V. Tarasco, E. Palumeri, R. Calabrese and R. Oggero. 2010. Lactobacillus reuteri DSM 17938 in infantile colic: A randomized, double-blind, placebo-controlled trial. Pediatrics. 126: e526-e533.
Siro. I., E. Kápolna, B. Kápolna and A. Lugasi. 2008. Functional food. Product development, marketing and consumer acceptance-a review. Appetite. 51: 456-467.
Tapiovaara, L., A. I. Pitkäranta and R. Korpela. 2016b. Probiotics and upper respiratory tract-a review. Pediatr. Infect. Dis. J. 1: 1-8.
Tapiovaara, L., A. Pitkaranta and R. Korpela. 2016a. Probiotics and the upper respiratory tract-a review. Pediatr. Infect. Dis. 1: 2573.
Teo, S. M., D. Mok, K. Pham, M. Kusel, M. Serralha and N. Troy. 2015. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 17: 704-715.
Valdez, J., M. Peral, M. Rachid, M. Santana and G. Perdigon. 2005. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: The potential use of probiotics in wound treatment. Clin. Microbiol. Infect. 11: 472-479.
Vouloumanou, E. K., G. C. Makris, D. E. Karageorgopoulos and M. E. Falagas. 2009. Probiotics for the prevention of respiratory tract infections: A systematic review. Int. J. Antimicrob. Agents. 34: 197.
Whelan, K. and E. M. Quigley. 2013. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr. Opin. Gastroenterol. 29: 184-189.
Wong, S. S., Z. Q. Toh, E. M. Dunne, E. K. Mulholland, M. L. Tang and R. M. Robins-Browne. 2013. Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG. BMC Res. Notes. 6: 135.
Wu, D. D., J. Song, S. Bartel, S. Krauss-Etschmann, M. G. Rots and M. N. Hylkema. 2018. The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach. Pharmacol. Ther. 182: 1-14.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Rafee H. Askandar, Nasim Ebrahimi
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Polytechnic Journal ; A Periodical Open Access Scientific Journal